首页> 外文OA文献 >Scanning Chimeragenesis: The Approach Used to Change Monoxygenase Cytochrome P450 BM3 into ω-Hydroxylase CYP4C7
【2h】

Scanning Chimeragenesis: The Approach Used to Change Monoxygenase Cytochrome P450 BM3 into ω-Hydroxylase CYP4C7

机译:扫描嵌合体生成:用于将单加氧酶细胞色素P450 BM3变为ω-羟化酶CYP4C7的方法

摘要

It is believed that the specificity of cytochrome P450 is determined by a specific set of protein fragments that form the Substrate Recognition Site (SRS-1) and are responsible for a particular orientation of the bound substrate relative to the activated oxygen atom. Cytochrome P450 BM3 (CYP102A1) from Bacillus megaterium, is known for its high catalytic activity. Wild type BM3 catalyzes the oxidation of medium and long chain fatty acids (C12-18), and of farnesol, but the two form different metabolites, forms 9-hydroxyfarnesol and 10,11- and 2,3-epoxyfarnesol in a ratio of 3:3:2 and 12-hydroxyfarnesol, respectively. CYP102A1 and CYP4C7 share a common substrate, farnesol. Therefore, CYP4C7 has become the target for homologous replacements in CYP102A1. CYP4C7 from Diploptera Punctata (Pacific Beetle Cockroach) only catalyzes farnesol to produce 12-hydroxyfarnesol as its primary metabolite, with no activity towards fatty acids. By using the technique of scanning chimeragenesis, in this work three generations of chimeras have created twenty chimeric proteins. By starting with CYP102A1 as the experimental model and employing sequential rounds of selective mutagenesis, the third generation mutant C(78-82,F87L,328-330) was produced, which catalyzed the 12- and 15-hydroxylation of farnesol as its major products in a 3:1 ratio with a hundred-fold increase in catalytic activity compared to the wild type CYP4C7, and a two-fold increase over CYP102A1. Based on the activity assay results for the chimeric proteins with substrates geranyl-geraniol, 10,11-epoxymethylfarnesoate (JH III), methylfarnesoate, farnesol, geraniol, 3,7-dimethyl-1-octanol, and lauric and palmitic acids, most chimeric proteins showed a change in substrate selectivity and/or regiospecificity. Scanning chimeragenesis can be used as a tool to not only study the relationship between the protein fragments that form the substrate binding site, but also to help elucidate the roles of substrate selectivity and regiospecificity among any two cytochromes P450. Furthermore, this investigation has resulted in the production of highly efficient chimeric enzymes that have previously evaded other methods of sequence modification by mutagenesis or directed evolution and chemical synthesis.
机译:据信,细胞色素P450的特异性由形成底物识别位点(SRS-1)并负责结合的底物相对于活化的氧原子的特定取向的一组特定的蛋白质片段决定。巨大芽孢杆菌的细胞色素P450 BM3(CYP102A1)以其高催化活性而闻名。野生型BM3催化中链和长链脂肪酸(C12-18)以及法尼醇的氧化,但是两者形成不同的代谢产物,形成9-羟基法尼醇以及10,11-和2,3-环氧法尼醇的比例为3分别为:3:2和12-羟基法尼醇。 CYP102A1和CYP4C7共享相同的底物法尼醇。因此,CYP4C7已成为CYP102A1同源替代的目标。来自点点双翅目(CYP4C7)的CYP4C7仅催化法尼醇产生12-羟基法尼醇作为其主要代谢产物,对脂肪酸没有活性。通过使用扫描嵌合体生成技术,在这项工作中,三代嵌合体产生了二十种嵌合蛋白。以CYP102A1为实验模型,并进行了连续轮次的选择性诱变,产生了第三代突变体C(78-82,F87L,328-330),其催化法呢醇的12和15羟基化反应是其主要产物。与野生型CYP4C7的比例为3:1,催化活性提高了100倍,比CYP102A1增长了2倍。基于具有底物香叶基香叶基香叶醇,10,11-环氧甲基法尼松酸酯(JH III),法呢醇,法呢醇,香叶醇,3,7-二甲基-1-辛醇以及月桂酸和棕榈酸的嵌合蛋白的活性测定结果蛋白显示底物选择性和/或区域特异性的变化。扫描嵌合体生成不仅可以用作研究形成底物结合位点的蛋白质片段之间关系的工具,而且可以帮助阐明任何两种细胞色素P450之间底物选择性和区域特异性的作用。此外,该研究已经导致产生了高效的嵌合酶,该酶先前避免了通过诱变或定向进化和化学合成进行序列修饰的其他方法。

著录项

  • 作者

    Chen Chiung-Kuang;

  • 作者单位
  • 年度 2007
  • 总页数
  • 原文格式 PDF
  • 正文语种 EN
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号